Table 2.
Treatment characteristics and treatment response in Cohort A and Cohort B treated with standard therapy (oral steroids) and ozone therapy.
| Patient characteristics | Cohort A (Steroid therapy only) (n = 23) | Cohort B (Steroid therapy and ozone therapy) (n = 24) | Value of p |
|---|---|---|---|
| Median follow-up time (months) | 12 (range, 12–35) | 13 (range, 12–23) | 0.447* |
| Number of ozone applications | NA | 16 (range, 10–25) | |
| Median week of steroid use | 26 (range, 16–36) | 12 (range, 8–32) | 0.001 |
| Median maximum methyl prednisolone dose per day | 16 mg (range, 8–32) | 16 mg (range, 8–32) | 0.650 |
| Response to four-month therapy after diagnosis | 0.005 | ||
| Complete response rate | 0% (0/23) | 37.5% (9/24) | |
| Partial response (>50% disappearance of lesions) | 65.2% (15/23) | 54.2% (13/24) | |
| Minimal response (<50% disappearance of lesions) | 30.4% (7/23) | 8.3% (2/24) | |
| No response/progression | 4.3% (1/23) | 0% (0/24) | |
| Complete response rate | 0% (0/23) | 37.5% (9/24) | 0.002 |
| One-year breast recurrence rate | 70% (16/23) | 21% (5/24) | 0.001 |
| Two-year breast recurrence rate | 73.9% (17/23) | 29.2% (7/24) | 0.003 |
*Mann–Whitney U-test was used. N.A. = not applicable.